Skip to content
ClinCalc Pro
Menu
Tetracycline antibiotic (with anti-ADH effect)

Demeclocycline

Brand names: Ledermycin

Used in: Hyponatraemia

Demeclocycline is a tetracycline antibiotic used in endocrinology principally to manage chronic hyponatraemia caused by the syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

In this setting it acts on the renal collecting ducts to reduce responsiveness to antidiuretic hormone, producing a reversible nephrogenic diabetes insipidus that promotes water excretion.

Prescribing in practice

  • It can be nephrotoxic, particularly in hepatic impairment, so renal function must be monitored and it is avoided in significant liver disease.
  • As a tetracycline it causes photosensitivity and is contraindicated in pregnancy and young children because of effects on teeth and bone.
  • Absorption is reduced by dairy products and by calcium, iron or antacids, which should be separated from dosing.

Monitoring

Monitor serum sodium and renal function during treatment for SIADH.

Counselling the patient

  • Avoid strong sun exposure and use sun protection because of photosensitivity.
  • Take separately from milk, indigestion remedies and iron or calcium supplements.
  • Attend for blood tests to check sodium and kidney function.

Evidence & guidelines

Demeclocycline is an established option for chronic SIADH where fluid restriction is insufficient; use should follow the SPC.

Reference: SmPC Ledermycin; UK Hyponatraemia Guidance (Spasovski et al. ESE 2014); Verbalis et al. Am J Med 2013; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.